You are here:Home-Chemical Inhibitors & Agonists-Ras-Raf-MAPK-ERK Pathway-MEK (MAP2K)-BI-847325
BI-847325

Chemical Structure : BI-847325

CAS No.: 1207293-36-4

BI-847325 (BI847325;BI 847325)

Catalog No.: PC-45572Not For Human Use, Lab Use Only.

BI-847325 is a potent, ATP-competitive MEK/Aurora kinase inhibitor, inhibts human Aurora A (IC50=25 nM) and Aurora C (IC50=16 nM).

Packing Price Stock Quantity
10 mg $168 In stock
25 mg $258 In stock
50 mg $428 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

BI-847325 is a potent, ATP-competitive MEK/Aurora kinase inhibitor, inhibts human Aurora A (IC50=25 nM) and Aurora C (IC50=16 nM).
BI-847325 also inhibits MEK1 (IC50=25 nM) and MEK2 (IC50=6 nM).
BI-847325 reduces expression of p-ERK and p-Histone 3 in multiple models of vemurafenib resistance.
BI-847325 decreases the expression of MEK and Mcl-1 and increases the expression of BIM.
BI-847325 is orally bioavailable.

Physicochemical Properties

M.Wt 464.5582
Formula C29H28N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

DMSO: ≥36 mg/mL

Chemical Name/SMILES

2-Propynamide, 3-[3-[[[4-[(dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-6-yl]-N-ethyl-

References

1. Phadke MS, et al. Mol Cancer Ther. 2015 Jun;14(6):1354-64.

2. Sini P, et al. Mol Cancer Ther. 2016 Oct;15(10):2388-2398.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: